Literature DB >> 19775836

Encephalitic alphaviruses.

Michele A Zacks1, Slobodan Paessler.   

Abstract

This review will cover zoonotic, encephalitic alphaviruses in the family Togaviridae. Encephalitic alphaviruses, i.e. Western- (WEEV), Eastern- (EEEV), Venezuelan equine encephalitis virus (VEEV) and, more rarely, Ross River virus, Chikungunya virus and Highlands J virus (HJV), are neuroinvasive and may cause neurological symptoms ranging from mild (e.g., febrile illness) to severe (e.g., encephalitis) in humans and equines. Among the naturally occurring alphaviruses, WEEV, EEEV and VEEV have widespread distributions in North, Central and South America. WEEV has found spanning the U.S. from the mid-West (Michigan and Illinois) to the West coast and extending to Canada with human cases reported in 21 states. EEEV is found along the Gulf (Texas to Florida) and Atlantic Coast (Georgia to New Hampshire), as well as in the mid-West (Wisconsin, Illinois and Michigan) and in Canada, with human cases reported in 19 states. In contrast, transmission of VEEV occurs predominantly in Central and South America. As with their geographical distribution, equine encephalitis viruses differ in their main mosquito vector species and their zoonotic potential. Copyright 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19775836      PMCID: PMC2814892          DOI: 10.1016/j.vetmic.2009.08.023

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  40 in total

1.  Control of Sindbis virus infection by antibody in interferon-deficient mice.

Authors:  A P Byrnes; J E Durbin; D E Griffin
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

2.  A novel, rapid assay for detection and differentiation of serotype-specific antibodies to Venezuelan equine encephalitis complex alphaviruses.

Authors:  Eryu Wang; Slobodan Paessler; Patricia V Aguilar; Darci R Smith; Lark L Coffey; Wenli Kang; Martin Pfeffer; James Olson; Patrick J Blair; Carolina Guevara; Jose Estrada-Franco; Scott C Weaver
Journal:  Am J Trop Med Hyg       Date:  2005-06       Impact factor: 2.345

3.  Complex-specific immunoglobulin M antibody patterns in humans infected with alphaviruses.

Authors:  C H Calisher; A O el-Kafrawi; M I Al-Deen Mahmud; A P Travassos da Rosa; C R Bartz; M Brummer-Korvenkontio; S Haksohusodo; W Suharyono
Journal:  J Clin Microbiol       Date:  1986-01       Impact factor: 5.948

4.  Recombinational history and molecular evolution of western equine encephalomyelitis complex alphaviruses.

Authors:  S C Weaver; W Kang; Y Shirako; T Rumenapf; E G Strauss; J H Strauss
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

5.  Pre- and post-exposure protection against Western equine encephalitis virus after single inoculation with adenovirus vector expressing interferon alpha.

Authors:  Josh Q H Wu; Nicole D Barabé; Ying-Min Huang; George A Rayner; Mary E Christopher; Fay L Schmaltz
Journal:  Virology       Date:  2007-08-29       Impact factor: 3.616

Review 6.  Venezuelan equine encephalitis.

Authors:  Scott C Weaver; Cristina Ferro; Roberto Barrera; Jorge Boshell; Juan-Carlos Navarro
Journal:  Annu Rev Entomol       Date:  2004       Impact factor: 19.686

7.  Genetically engineered, live attenuated vaccines for Venezuelan equine encephalitis: testing in animal models.

Authors:  William D Pratt; Nancy L Davis; Robert E Johnston; Jonathan F Smith
Journal:  Vaccine       Date:  2003-09-08       Impact factor: 3.641

8.  Recombinant alphaviruses are safe and useful serological diagnostic tools.

Authors:  Haolin Ni; Nadezhda E Yun; Michele A Zacks; Scott C Weaver; Robert B Tesh; Amelia P Travassos da Rosa; Ann M Powers; Ilya Frolov; Slobodan Paessler
Journal:  Am J Trop Med Hyg       Date:  2007-04       Impact factor: 2.345

9.  Single-dose, fast-acting vaccine candidate against western equine encephalitis virus completely protects mice from intranasal challenge with different strains of the virus.

Authors:  Nicole D Barabé; George A Rayner; Mary E Christopher; Les P Nagata; Josh Q H Wu
Journal:  Vaccine       Date:  2007-06-14       Impact factor: 3.641

10.  Inhibition of alphavirus infection in cell culture and in mice with antisense morpholino oligomers.

Authors:  Slobodan Paessler; Rene Rijnbrand; David A Stein; Haolin Ni; Nadezhda E Yun; Natallia Dziuba; Viktoriya Borisevich; Alexey Seregin; Yinghong Ma; Robert Blouch; Patrick L Iversen; Michele A Zacks
Journal:  Virology       Date:  2008-05-12       Impact factor: 3.616

View more
  85 in total

1.  Manipulation of host factors optimizes the pathogenesis of western equine encephalitis virus infections in mice for antiviral drug development.

Authors:  Pennelope K Blakely; Phillip C Delekta; David J Miller; David N Irani
Journal:  J Neurovirol       Date:  2014-11-01       Impact factor: 2.643

2.  Venezuelan and western equine encephalitis virus E1 liposome antigen nucleic acid complexes protect mice from lethal challenge with multiple alphaviruses.

Authors:  Amber B Rico; Aaron T Phillips; Tony Schountz; Donald L Jarvis; Ronald B Tjalkens; Ann M Powers; Ken E Olson
Journal:  Virology       Date:  2016-09-12       Impact factor: 3.616

3.  Entry Sites of Venezuelan and Western Equine Encephalitis Viruses in the Mouse Central Nervous System following Peripheral Infection.

Authors:  Aaron T Phillips; Amber B Rico; Charles B Stauft; Sean L Hammond; Tawfik A Aboellail; Ronald B Tjalkens; Ken E Olson
Journal:  J Virol       Date:  2016-05-27       Impact factor: 5.103

4.  Alphavirus-induced encephalomyelitis: antibody-secreting cells and viral clearance from the nervous system.

Authors:  Talibah U Metcalf; Diane E Griffin
Journal:  J Virol       Date:  2011-08-24       Impact factor: 5.103

5.  Hypervariable domains of nsP3 proteins of New World and Old World alphaviruses mediate formation of distinct, virus-specific protein complexes.

Authors:  Niall J Foy; Maryna Akhrymuk; Ivan Akhrymuk; Svetlana Atasheva; Alain Bopda-Waffo; Ilya Frolov; Elena I Frolova
Journal:  J Virol       Date:  2012-12-05       Impact factor: 5.103

6.  Current strategic thinking for the development of a trivalent alphavirus vaccine for human use.

Authors:  Daniel N Wolfe; D Gray Heppner; Shea N Gardner; Crystal Jaing; Lesley C Dupuy; Connie S Schmaljohn; Kevin Carlton
Journal:  Am J Trop Med Hyg       Date:  2014-05-19       Impact factor: 2.345

7.  Genome-wide RNAi screen identifies SEC61A and VCP as conserved regulators of Sindbis virus entry.

Authors:  Debasis Panda; Patrick P Rose; Sheri L Hanna; Beth Gold; Kaycie C Hopkins; Randolph B Lyde; Michael S Marks; Sara Cherry
Journal:  Cell Rep       Date:  2013-12-12       Impact factor: 9.423

8.  Ablation of Programmed -1 Ribosomal Frameshifting in Venezuelan Equine Encephalitis Virus Results in Attenuated Neuropathogenicity.

Authors:  Joseph A Kendra; Cynthia de la Fuente; Ashwini Brahms; Caitlin Woodson; Todd M Bell; Bin Chen; Yousuf A Khan; Jonathan L Jacobs; Kylene Kehn-Hall; Jonathan D Dinman
Journal:  J Virol       Date:  2017-01-18       Impact factor: 5.103

9.  β-d-N 4-Hydroxycytidine Is a Potent Anti-alphavirus Compound That Induces a High Level of Mutations in the Viral Genome.

Authors:  Nadya Urakova; Valeriya Kuznetsova; David K Crossman; Arpine Sokratian; David B Guthrie; Alexander A Kolykhalov; Mark A Lockwood; Michael G Natchus; Michael R Crowley; George R Painter; Elena I Frolova; Ilya Frolov
Journal:  J Virol       Date:  2018-01-17       Impact factor: 5.103

Review 10.  Zoonotic encephalitides caused by arboviruses: transmission and epidemiology of alphaviruses and flaviviruses.

Authors:  Yun Young Go; Udeni B R Balasuriya; Chong-Kyo Lee
Journal:  Clin Exp Vaccine Res       Date:  2013-12-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.